American Well Corporation (NYSE:AMWL) Given Consensus Recommendation of "Hold" by Brokerages

Key Points

• Analysts rate AMWL a consensus "Hold": seven firms cover the stock (1 sell, 5 hold, 1 buy) with an average 12‑month target of $7.40, and recent price‑target cuts from Stifel and Morgan Stanley underscore cautious sentiment.
• Insider and institutional activity is mixed: insider Dmitry Zamansky sold 5,575 shares at $5.30 and insiders sold 9,664 shares last quarter (insiders own 12.8%), while firms like Goldman Sachs and Jane Street materially increased their stakes, leaving institutions with about 56% ownership.
• Company remains unprofitable but recently beat estimates: Q1 EPS was ($1.52) vs. ($1.59) expected and revenue was $55.3M, yet Amwell has negative margins/ROE and analysts project roughly ($9.34) EPS for the year; shares trade near $5.55 with a market cap around $92M.

Shares of American Well Corporation (NYSE:AMWL - Get Free Report) have been given an average recommendation of "Hold" by the seven research firms that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation and one has assigned a buy recommendation to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $7.40.

AMWL has been the subject of several analyst reports. Stifel Nicolaus lowered their price objective on American Well from $6.00 to $5.00 and set a "hold" rating for the company in a research note on Friday, February 13th. Wall Street Zen raised American Well from a "sell" rating to a "hold" rating in a research note on Sunday, March 22nd. Morgan Stanley lowered their price objective on American Well from $10.50 to $6.00 and set an "equal weight" rating for the company in a research note on Thursday, December 18th. Finally, Weiss Ratings reiterated a "sell (e+)" rating on shares of American Well in a report on Wednesday, January 21st.

Insider Buying and Selling at American Well

In other news, insider Dmitry Zamansky sold 5,575 shares of the stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $5.30, for a total value of $29,547.50. Following the sale, the insider directly owned 241,080 shares in the company, valued at approximately $1,277,724. This represents a 2.26% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders sold 9,664 shares of company stock valued at $51,219 in the last quarter. Corporate insiders own 12.80% of the company's stock.

Institutional Investors Weigh In On American Well

Several hedge funds and other institutional investors have recently modified their holdings of AMWL. Goldman Sachs Group Inc. raised its holdings in shares of American Well by 280.6% in the first quarter. Goldman Sachs Group Inc. now owns 64,760 shares of the company's stock worth $510,000 after buying an additional 47,745 shares during the period. Jane Street Group LLC raised its holdings in shares of American Well by 232.9% in the first quarter. Jane Street Group LLC now owns 64,112 shares of the company's stock worth $505,000 after buying an additional 44,852 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of American Well by 16.5% in the second quarter. JPMorgan Chase & Co. now owns 14,720 shares of the company's stock worth $131,000 after buying an additional 2,081 shares during the period. Norges Bank purchased a new stake in shares of American Well in the second quarter worth approximately $250,000. Finally, Engineers Gate Manager LP purchased a new stake in shares of American Well in the second quarter worth approximately $101,000. 56.05% of the stock is currently owned by hedge funds and other institutional investors.

American Well Price Performance

NYSE:AMWL opened at $5.55 on Wednesday. The firm has a market capitalization of $91.85 million, a price-to-earnings ratio of -0.93 and a beta of 1.39. American Well has a 1 year low of $3.71 and a 1 year high of $9.15. The business has a 50 day simple moving average of $5.35 and a 200-day simple moving average of $5.02.

American Well (NYSE:AMWL - Get Free Report) last posted its quarterly earnings data on Thursday, February 12th. The company reported ($1.52) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.59) by $0.07. The business had revenue of $55.31 million during the quarter, compared to analyst estimates of $52.71 million. American Well had a negative return on equity of 35.33% and a negative net margin of 38.38%. As a group, analysts expect that American Well will post -9.34 earnings per share for the current fiscal year.

American Well Company Profile

American Well, operating under the trade name Amwell, is a Boston-based digital health company that develops and delivers telehealth solutions to healthcare providers, payers, employers and patients. Through its cloud-based platform, the company enables secure virtual visits, remote patient monitoring and integrated care coordination across a range of medical disciplines, including primary care, behavioral health, chronic disease management and urgent care.

The company's core offering, the Amwell Telehealth Platform, facilitates live video consultations, asynchronous messaging, e-prescribing and electronic health record integration.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.